Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.5B | 1.4B | 1.4B | 1.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 45.3M | 75.1M | 44.0M | 41.7M |
| Other operating expenses | 29.0M | 30.1M | 31.5M | 34.9M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | 8K | 1K | — | — |
| Expense | 1.3M | 277K | 279K | 551K |
| Other income expense | 0 | 0 | 0 | 0 |
| Pretax income | 2.4B | 2.7B | 2.7B | 2.6B |
| Tax provision | 443.9M | 430.2M | 449.0M | 415.5M |
| Net income | 2.0B | 2.3B | 2.3B | 2.1B |
| Basic EPS | 1.0 | — | 1.2 | 1.1 |
| Diluted EPS | 1.0 | — | 1.2 | 1.1 |
| Basic average shares | 1.9B | — | 1.9B | 2.0B |
| Diluted average shares | 1.9B | — | 1.9B | 2.0B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 2.0B | 2.3B | 2.3B | 2.1B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |